Ledger.Open graph →
SEC Form D · filed March 7, 2025

GT Biopharma, Inc

Offering
$1.3M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Bruce Wendel · San Francisco, CADirectorCharles Casamento · San Diego, CADirectorMichael Breen · Los Angeles, CAExec · DirectorRajesh Shrotriya · San Francisco, CADirectorAlan Urban · San Francisco, CAExecBruce Wendel · San Francisco, CADirectorCharles Casamento · CARLSBAD, CADirectorMichael Breen · San Francisco, CAExec · DirectorRajesh Shrotriya · San Francisco, CADirectorAlan Urban · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗